Search results
Moderna and OpenAI Are Teaming Up, but Does That Make the Stock a Buy? | The Motley Fool
The Motley Fool· 18 hours agoModerna (MRNA -4.38%) and OpenAI are collaborating to bring artificial intelligence (AI) to every...
Wealthspire Advisors LLC Has $301,000 Stock Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 24 hours agoWealthspire Advisors LLC trimmed its stake in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 7.9% in the fourth quarter, according to its most recent disclosure with the Securities ...
Moderna's RSV Vaccine Approval Faces Setback as FDA Delays Decision
Homenewshere.com· 2 days agoModerna announced that the FDA had delayed approval of its RSV vaccine to the end of May due to...
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 4 days ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
Positive week for Moderna, Inc. (NASDAQ:MRNA) institutional investors who lost 6.8% over the past...
Simply Wall St. via Yahoo Finance· 4 days agoKey Insights Significantly high institutional ownership implies Moderna's stock price is sensitive...
If You'd Invested $1,000 in Moderna Stock 5 Years Ago, Here's How Much You'd Have Today
Motley Fool via Yahoo Finance· 4 days agoFive years ago, pharmaceutical company Moderna (NASDAQ: MRNA) was mostly unknown. It was developing...
Moderna’s mRNA dreams meet reality with first post-COVID shot - The Boston Globe
The Boston Globe· 3 days agoModerna’s stock dropped 45 percent last year, making it the worst-performing large biotech in the...
FDA delays decision on Moderna RSV vaccine
BioPharma Dive via Yahoo Finance· 3 days agoThe regulator cited “administrative constraints,” rather than any issue with Moderna’s trial data, for missing a May 12 deadline, the company said.
Moderna Stock Seesaws After The FDA Throws It A Curveball
Investor's Business Daily· 3 days agoThe FDA was due to make a decision by May 12. Moderna emphasized the FDA has not said it found any...
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters via Yahoo News· 3 days agoModerna's shares fell 3% to $119.02 in early trading. The Food and Drug Administration's move...